Clinical AI company Sensyne Health has signed a new Strategic Research Agreement (SRA) with US-based healthcare provider Sentara Healthcare. Under the deal, Sensyne will have access to de-identified patient data covering Sentara’s 3.6 million patients and the two companies will collaborate on new clinical algorithms to support patients with chronic kidney disease and congestive heart failure….
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
 with US-based healthcare provider Sentara Healthcare.){kind=link}